Refine
Year of publication
Language
- English (22)
Has Fulltext
- yes (22)
Is part of the Bibliography
- no (22)
Keywords
- acute-on-chronic liver failure (3)
- inflammation (3)
- ACLF (2)
- Cirrhosis (2)
- Inflammation (2)
- Liver diseases (2)
- cirrhosis (2)
- hepatitis C virus (2)
- resistance mutation (2)
- serine protease (NS3-4A) (2)
- Ascites (1)
- Blood plasma (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- Case report (1)
- Cell cultures (1)
- Clinical phenotype (1)
- Crystal structure (1)
- Dimers (Chemical physics) (1)
- Eicosanoids (1)
- Fatty acids (1)
- Fatty liver (1)
- Frameshift (1)
- GSK3α (1)
- GSK3β (1)
- Gastrointestinal tract (1)
- Intracellular pathogens (1)
- Liver (1)
- Liver fibrosis (1)
- MEN1 (1)
- Microbial mutation (1)
- NASH (1)
- NS5A (1)
- RNA virus (1)
- RNA viruses (1)
- Truncating mutation (1)
- Viral core (1)
- Viral replication (1)
- Vitamin D (1)
- Vitamin D deficiency (1)
- acute‐on‐chronic liver failure (1)
- adaptation (1)
- alcoholic fatty liver disease (1)
- arachidonic acid (1)
- ascites (1)
- bacterial translocation (1)
- circulation (1)
- cytokines (1)
- decompensated liver cirrhosis (1)
- drug resistance (1)
- evolution (1)
- exosomes (1)
- fibrosis (1)
- hemodynamic (1)
- hepatitis C virus (HCV) (1)
- hepatitis E virus (1)
- hospital admission (1)
- host-targeting antivirals (1)
- immune escape (1)
- innate immunity (1)
- insulin resistance (1)
- interactions (1)
- interferon (1)
- interferons (1)
- lipid droplets (1)
- lipidomics (1)
- liver cirrhosis (1)
- liver immunology (1)
- macrophages (1)
- male (1)
- mechanical ventilation (1)
- membrane remodeling (1)
- metabolomics (1)
- miR-122 (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular dynamics (1)
- mortality (1)
- non-alcoholic fatty liver disease (1)
- omega-3 fatty acids (1)
- phospholipid (1)
- portal hypertension (1)
- protease inhibitor (1)
- protein evolution (1)
- protein folding (1)
- pulmonary failure (1)
- replicative fitness (1)
- respiratory failure (1)
- structure constraints (1)
- viral fitness (1)
- viral replication (1)
Institute
- Medizin (20)
- Frankfurt Institute for Advanced Studies (FIAS) (2)
- Physik (2)
Inhibitors against the NS3-4A protease of hepatitis C virus (HCV) have proven to be useful drugs in the treatment of HCV infection. Although variants have been identified with mutations that confer resistance to these inhibitors, the mutations do not restore replicative fitness and no secondary mutations that rescue fitness have been found. To gain insight into the molecular mechanisms underlying the lack of fitness compensation, we screened known resistance mutations in infectious HCV cell culture with different genomic backgrounds. We observed that the Q41R mutation of NS3-4A efficiently rescues the replicative fitness in cell culture for virus variants containing mutations at NS3-Asp168. To understand how the Q41R mutation rescues activity, we performed protease activity assays complemented by molecular dynamics simulations, which showed that protease-peptide interactions far outside the targeted peptide cleavage sites mediate substrate recognition by NS3-4A and support protease cleavage kinetics. These interactions shed new light on the mechanisms by which NS3-4A cleaves its substrates, viral polyproteins and a prime cellular antiviral adaptor protein, the mitochondrial antiviral signaling protein MAVS. Peptide binding is mediated by an extended hydrogen-bond network in NS3-4A that was effectively optimized for protease-MAVS binding in Asp168 variants with rescued replicative fitness from NS3-Q41R. In the protease harboring NS3-Q41R, the N-terminal cleavage products of MAVS retained high affinity to the active site, rendering the protease susceptible for potential product inhibition. Our findings reveal delicately balanced protease-peptide interactions in viral replication and immune escape that likely restrict the protease adaptive capability and narrow the virus evolutionary space.
The spike protein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is required for cell entry and is the primary focus for vaccine development. In this study, we combined cryo–electron tomography, subtomogram averaging, and molecular dynamics simulations to structurally analyze S in situ. Compared with the recombinant S, the viral S was more heavily glycosylated and occurred mostly in the closed prefusion conformation. We show that the stalk domain of S contains three hinges, giving the head unexpected orientational freedom. We propose that the hinges allow S to scan the host cell surface, shielded from antibodies by an extensive glycan coat. The structure of native S contributes to our understanding of SARS-CoV-2 infection and potentially to the development of safe vaccines.